We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Harnessing the Immune System Against Cancer by Targeting CD25

Video   Mar 16, 2021 | Taken from CRUK, YouTube

 

The shared CD25 activation mechanism on regulatory and effector T cells has been a big challenge when designing immunotherapy drugs. Cancer Research UK scientists from University College London in collaboration with Roche, have developed a new antibody that can target CD25 specifically on regulatory T cells while leaving effector T cells intact. Watch this antibody in action in this short animation.

Read the Nature paper on this area of research here.  


 
 
 
Advertisement
 

Recommended Videos

Coronavirus Variants: What You Need To Know

Video

What do scientists mean when they talk about variants and what might this mean for the future of the pandemic?

WATCH NOW

Why Is the Gut Microbiome Important for Our Health?

Video

British Society for Immunology member and professor of immunology at Imperial College London Danny Altmann discusses what the gut microbiome is and why researchers think it could be important for helping our immune systems to function correctly.

WATCH NOW

Structural Biology Goes Viral With Dr Albert Konijnenberg

Video

What can integrative structural biology bring to viral research? That is the topic explored in this week's Teach Me in 10 at Technology Networks, featuring Dr Albert Konijnenberg.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE